X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.prnewswire.com/news-releases/first-patient-dosed-in-phase-2-clinical-study-of-palatins-bremelanotide-co-administered-with-tirzepatide-glp-1-for-the-treatment-of-obesity-302228157.html
https://www.biospace.com/drug-development/lillys-tirzepatide-cuts-type-2-diabetes-risk-by-94-in-overweight-obese-adults
https://www.fiercebiotech.com/biotech/lilly-catalyze360-looks-connect-emerging-biotechs-across-all-areas-exec
https://www.fiercepharma.com/pharma/eli-lilly-lifts-guidance-3b-supplies-mounjaro-and-zepbound-recover
https://www.prnewswire.com/news-releases/lillys-tirzepatide-successful-in-phase-3-study-showing-benefit-in-adults-with-heart-failure-with-preserved-ejection-fraction-and-obesity-302211753.html
https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lillys-weight-loss-drug-tirzepatide-gets-approval-china-2024-07-19/
https://www.fiercepharma.com/marketing/eli-lilly-vaults-simone-biles-head-mounjaro-ad-campaign-partnering-olympian-tv-spot
https://www.reuters.com/business/healthcare-pharmaceuticals/india-panel-urges-drug-regulator-approve-lillys-obesity-drug-mounjaro-2024-07-01/
https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-says-semaglutide-approved-long-term-weight-management-china-2024-06-25/
https://www.fiercebiotech.com/research/terns-ex-mash-drug-cuts-fat-not-muscle-or-food-intake-glp-1-combo-mice
https://www.reuters.com/business/healthcare-pharmaceuticals/weight-loss-drug-zepbound-resolves-sleep-apnea-up-52-patients-lilly-says-2024-06-21/
https://www.reuters.com/business/healthcare-pharmaceuticals/doctors-must-keep-prescriptions-ozempic-check-danish-regulator-says-2024-06-24/
https://www.fiercebiotech.com/research/when-wegovy-stops-weight-gain-starts-could-glp-1-gene-therapy-change
https://www.nbcnews.com/health/health-news/lilly-maker-zepbound-files-lawsuits-compounded-tirzepatide-rcna158021
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ozempic-frenzy-lures-rich-indians-to-brave-the-gray-market/articleshow/111099441.cms
https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-exec-says-seeing-out-pocket-payments-obesity-drug-us-2024-06-10/
https://www.prnewswire.com/news-releases/lillys-tirzepatide-was-superior-to-placebo-for-mash-resolution-and-more-than-half-of-patients-achieved-improvement-in-fibrosis-at-52-weeks-302167649.html
https://www.fiercepharma.com/pharma/lilly-touts-fibrosis-win-it-pads-case-tirzepatide-mash
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-5-2024-58484.pdf
https://www.fiercepharma.com/pharma/lilly-wins-nice-endorsement-tirzepatide-obesity-catch
https://www.reuters.com/business/healthcare-pharmaceuticals/britain-considers-offering-lilly-weight-loss-drug-better-terms-than-wegovy-2024-06-04/
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-invests-further-53-bln-new-indiana-site-obesity-drug-demand-soars-2024-05-24/
https://www.prnewswire.com/news-releases/lilly-increases-manufacturing-investment-to-9-billion-at-newest-indiana-site-to-boost-api-production-for-tirzepatide-and-pipeline-medicines-302155135.html
https://www.fiercepharma.com/pharma/eli-lilly-inks-settlement-med-spa-selling-knockoff-mounjaro-zepbound
https://www.reuters.com/business/healthcare-pharmaceuticals/indias-cipla-beats-q4-profit-estimates-2024-05-10/
https://www.livemint.com/news/amgen-soars-after-ceo-gives-update-on-experimental-obesity-drug-11714686711922.html
https://www.prnewswire.com/news-releases/palatin-announces-fda-clearance-of-ind-application-for-the-co-administration-of-bremelanotide-with-tirzepatide-glp-1-for-the-treatment-of-obesity-302134204.html
https://investor.lilly.com/news-releases/news-release-details/tirzepatide-reduced-sleep-apnea-severity-nearly-two-thirds
https://www.prnewswire.com/news-releases/tirzepatide-reduced-sleep-apnea-severity-by-up-to-nearly-two-thirds-in-adults-with-obstructive-sleep-apnea-osa-and-obesity-302118929.html
https://www.reuters.com/business/healthcare-pharmaceuticals/most-doses-lillys-mounjaro-zepbound-limited-availability-us-fda-says-2024-04-17/
https://endpts.com/eli-lilly-loses-case-against-florida-compounding-pharmacy/
https://www.reuters.com/business/healthcare-pharmaceuticals/some-doses-lillys-zepbound-short-supply-through-april-end-us-fda-says-2024-04-03/
https://www.fiercepharma.com/pharma/unprecedented-demand-eli-lillys-zepbound-sparks-nationwide-supply-constraints
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-weight-loss-drug-zepbound-new-us-prescriptions-surpass-wegovy-first-time-2024-03-15/
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-partners-with-amazon-deliver-zepbound-other-drugs-2024-03-13/
https://endpts.com/cbo-hints-that-medicare-may-soon-cover-obesity-drugs-for-their-cardiovascular-benefits/
https://www.fiercepharma.com/pharma/eli-lilly-deeply-concerned-over-fake-and-compounded-versions-its-mounjaro-zepbound
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-ceo-says-its-obesity-drug-could-enter-india-early-2025-2024-02-28/
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-review-lillys-mounjaro-multi-dose-pen-2024-02-19/
https://www.reuters.com/business/healthcare-pharmaceuticals/britain-sees-launch-lillys-weight-loss-drug-mounjaro-2024-02-14/
https://endpts.com/fda-goes-after-websites-marketing-unapproved-semaglutide-tirzepatide/
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/fda-warns-online-vendors-selling-misbranded-weight-loss-diabetes-drugs/107680280#:~:text=New%20Delhi%3A%20The%20U.S.%20Food,diabetes%20and%20weight%2Dloss%20drugs.
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-sees-2024-profit-above-estimates-strong-demand-weight-loss-drug-2024-02-06/
https://www.fiercepharma.com/pharma/eli-lilly-mounts-clinical-and-commercial-case-tirzepatide-mounjaro-zepbound-come-their-own
https://endpts.com/lillys-weight-loss-drug-zepbound-generates-175-8m-in-q4-as-mounjaro-sales-also-rise/
https://www.reuters.com/business/healthcare-pharmaceuticals/fda-website-shows-limited-availability-some-doses-lillys-mounjaro-2024-02-05/
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-talks-with-germany-over-weight-loss-drug-coverage-spiegel-2024-01-29/
Market Place
Share 
